Doxylamine succinate 20 mg / pyridoxine HCl 12HR 20 mg Extended Release Oral Tablet
RxNorm 1999651
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1999651 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: doxylamine succinate 20 mg / pyridoxine HCl 12HR 20 mg Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
12 HR doxylamine succinate 20 mg / pyridoxine hydrochloride 20 mg Extended Release Oral Tablet
(Atom ID: 12334755)
SYPrescribable
Synonym (SY):
12 HR doxylamine succinate 20 mg / vit-B6 Hydrochloride 20 mg Extended Release Oral Tablet
(Atom ID: 9733641)
SYPrescribable
Synonym (SY):
12 HR doxylamine succinate 20 mg / vitamin B6 Hydrochloride 20 mg Extended Release Oral Tablet
(Atom ID: 9733642)
PSNPrescribable
Prescribable Name (PSN):
Doxylamine succinate 20 mg / pyridoxine HCl 12HR 20 mg Extended Release Oral Tablet
(Atom ID: 9733175)
SYPrescribable